Binciken MRI da aka yi a cikin gwajin STEP UP ya duba abin da ke faruwa bayan makonni 72 na amfani da semaglutide mai ƙarfi (7.2 mg) akan tsarin jiki, ciki har da tsokar cinyoyi. An sami raguwar kitse sosai, kusan lita 11 idan aka kwatanta da placebo, kuma kitse a cikin tsokar cinyoyi ya ragu sosai. Girman tsokar cinyoyi ya ragu da kusan lita 1.1, canjin da bai kai matsayin ƙididdiga ba (p = 0.07) amma tazara na dogara tana nuni da asara. Tunda an duba mutum 55 kawai, tare da placebo guda shida, kuma kamfanin Novo Nordisk ya shiga cikin binciken, sakamakon na nuni ne kawai ba tabbatacce ba.
This page is available in